Early results of two Phase III studies with Sanofi-Synthelabo’s Acomplia (rimonabant), the first in a new class of therapeutics called Selective CB1 Blockers, indicate that overweight/obese patients with untreated dyslipidemia (high triglycerides and/or high total cholesterol/HDL cholesterol ratio) lost weight …

Are you an obese person? If you are then you are on the right website. This website wants to help you lose weight and achieve your normal weight. How can you do that? Simple, you use Acomplia. What is …

Lose the Pounds, Make the Dollars and Find the Time!YOU CAN ATTAIN THE GOAL YOU SET THIS YEAR!! Pounds, dollars and minutes are on the minds of most of us this time of year. No matter what you …